Sulaiman Al Habib chairman says 2020 results improved despite challenges; growth plans remain intact

Dr. Sulaiman Al Habib Medical Group’s (HMG) 2020 financial results improved compared to the previous year, despite challenging periods amid movement restrictions, board chairman Dr. Sulaiman Al Habib said in a statement today, Feb. 21, 2021.

Overall, the group witnessed a steady patient volume compared to the previous year, as patient activity recovered during the second half of 2020.

As in previous years, the hospitals segment continued to drive the group’s performance. The pharmacies business also continued its positive performance by enhancing e-pharmacy services for a better client experience.

“Our growth plans remain intact, with four new hospital projects in Riyadh and Jeddah all progressing well,” the chairman affirmed.

“We look forward to the year ahead, which witnessed the opening of our primary Care Center in Riyadh’s Diplomatic Quarter, and continuing to deliver efficiency, growth and unrivalled patient care,” Al Habib concluded.

HMG posted a net profit after Zakat and tax of SAR 1.055 billion in 2020, a rise of 21%, compared to SAR 870.2 million in 2019, Argaam reported.